I am a corporate finance executive with over twenty years of progressive hands-on experience building and leading life science companies through the odyssey of product development, approval and commercialization. I have an understanding of the specific challenges of a life science company, development cycles, funding, licensing/partnering negotiations, commercial challenges and compliance requirements. I also have strong public company expertise, including SEC reporting, investor relations, debt and equity issuances and Sarbanes-Oxley Act compliance.